Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Rupatadine on Driving Performance
NCT00162786Phase 4Terminated
- Sponsor
- Uriach
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rupatadine in allergic rhinitis (AR) and urticaria (3 arms), sponsored by Uriach. Primary endpoint: Actual driving performance (Standard Deviation of Lateral Position). Started May 2005; status: terminated.
02
Drugs
rupatadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on NCT00162786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162786.